Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03732547
What this trial is testing

Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Not applicableUnknownNCT06325826
What this trial is testing

The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs

Who this might be right for
Hepatocellular Carcinoma
Egyptian Liver Hospital 500
Not applicableNot Yet RecruitingNCT07584317
What this trial is testing

AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)

Who this might be right for
Hepatocellular Carcinoma
Gao-jun Teng 1,170
Not applicableNot Yet RecruitingNCT06708650
What this trial is testing

Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPD-1 Inhibitors
Guiping People's Hospital 50
Not applicableStudy completedNCT04891874
What this trial is testing

Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 76
Not applicableStudy completedNCT01767597
What this trial is testing

Application of HBV Rapid Tests as a Tool for Wide-Use Screening

Who this might be right for
Hepatitis BLiver CirrhosisCarcinoma, Hepatocellular
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 1,000
Testing effectiveness (Phase 2)Study completedNCT02471313
What this trial is testing

Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization

Who this might be right for
Liver CancerLiver NeoplasmHepatocellular Carcinoma+1 more
National Institutes of Health Clinical Center (CC) 3
Very early researchUnknownNCT04048317
What this trial is testing

Effectiveness of Drug Eluting TACE in Primary HCC

Who this might be right for
Hepatic Cell Carcinoma
Assiut University 75
Early research (Phase 1)UnknownNCT04104074
What this trial is testing

Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital 20
Testing effectiveness (Phase 2)Study completedNCT04264260
What this trial is testing

Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment

Who this might be right for
Hepatocellular Carcinoma Stage IIIBCholangiocarcinoma, IntrahepaticCholangiocarcinoma; With Hepatocellular Carcinoma+1 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 42
Testing effectiveness (Phase 2)Study completedNCT04518852
What this trial is testing

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsDigestive System Neoplasms+5 more
Sichuan Cancer Hospital and Research Institute 27
Large-scale testing (Phase 3)Active Not RecruitingNCT03186898
What this trial is testing

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v7Unresectable Hepatocellular Carcinoma
NRG Oncology 115
Testing effectiveness (Phase 2)UnknownNCT01834963
What this trial is testing

P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Kansai Hepatobiliary Oncology Group 66
Not applicableUnknownNCT02145013
What this trial is testing

Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma

Who this might be right for
Primary Liver Cancers
Henri Mondor University Hospital 200
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Early research (Phase 1)UnknownNCT02293850
What this trial is testing

Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Oncolys BioPharma Inc 18
Not applicableLooking for participantsNCT07224750
What this trial is testing

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)+3 more
City of Hope Medical Center 1,000
Early research (Phase 1)Looking for participantsNCT07018518
What this trial is testing

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaAdult
Chinese PLA General Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06664996
What this trial is testing

Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 33
Early research (Phase 1)UnknownNCT04677088
What this trial is testing

TCR-Redirected T Cell Treatment in Patients With Recurrent HBV-related Hepatocellular Carcinoma Post Liver Transplantation

Who this might be right for
Recurrent Hepatocellular Carcinoma
Xiaoshun He 7
Next Page